AU2597897A - Peptide ligands of the urokinase receptor - Google Patents

Peptide ligands of the urokinase receptor

Info

Publication number: AU2597897A
Authority: AU; Australia
Prior art keywords: peptide ligands; urokinase receptor; urokinase; receptor; ligands
Prior art date: 1996-03-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU25978/97A

Inventor

Harold A. Chapman

Michael Doyle

Steven Rosenberg

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Brigham and Womens Hospital Inc

Novartis Vaccines and Diagnostics Inc

Original Assignee

Brigham and Womens Hospital Inc

Chiron Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-28

Filing date

1997-03-28

Publication date

1997-10-17

1997-03-28 Application filed by Brigham and Womens Hospital Inc, Chiron Corp filed Critical Brigham and Womens Hospital Inc

1997-10-17 Publication of AU2597897A publication Critical patent/AU2597897A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70546—Integrin superfamily
- C07K14/7055—Integrin beta1-subunit-containing molecules, e.g. CD29, CD49
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Molecular Biology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Cell Biology (AREA)
Immunology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU25978/97A 1996-03-28 1997-03-28 Peptide ligands of the urokinase receptor Abandoned AU2597897A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US62336196A	1996-03-28	1996-03-28
US08623361		1996-03-28
PCT/US1997/005199 WO1997035969A2 (en)	1996-03-28	1997-03-28	Peptide ligands of the urokinase receptor

Publications (1)

Publication Number	Publication Date
AU2597897A true AU2597897A (en)	1997-10-17

Family

ID=24497795

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU25978/97A Abandoned AU2597897A (en)	1996-03-28	1997-03-28	Peptide ligands of the urokinase receptor

Country Status (4)

Country	Link
EP (1)	EP0906419A2 (en)
JP (2)	JP4088344B2 (en)
AU (1)	AU2597897A (en)
WO (1)	WO1997035969A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR020101A1 (en) *	1998-07-01	2002-04-10	Cancerforskingsfonden Af 1989	A PEPTIDE ANTAGONIST OF THE HUMAN UROQUINASE RECEPTOR, PHARMACEUTICAL COMPOSITION CONTAINING HIM, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND METHODOPARA TO SELECT AN ADEQUATE PEPTIDE ANTAGONIST.
EP0982036A1 (en) *	1998-08-28	2000-03-01	Wilex Biotechnology GmbH	Modulation of Beta2 -integrin-mediated cell adhesion
DK2319928T3 (en)	1998-10-23	2013-06-24	Kirin Amgen Inc	Dimeric thrombopoietic peptidomimetics that bind to MPL receptor and have thrombopoietic activity
US6660843B1 (en)	1998-10-23	2003-12-09	Amgen Inc.	Modified peptides as therapeutic agents
US7488590B2 (en)	1998-10-23	2009-02-10	Amgen Inc.	Modified peptides as therapeutic agents
CA2407086A1 (en) *	2000-04-21	2001-11-01	Amgen, Inc.	Integrin/adhesion antagonists
US20030054348A1 (en) *	2000-05-09	2003-03-20	Blume Arthur J.	Methods of identifying the activity of gene products
AU2002358158A1 (en) *	2001-12-19	2003-06-30	D. Collen Research Foundation	Use of urokinase receptor antagonists to modulate ischemiareperfusion injury
EP1773400A2 (en)	2004-07-08	2007-04-18	Amgen Inc.	Therapeutic peptides
CN101103045B (en)	2004-09-24	2015-11-25	安姆根有限公司	The Fc molecule modified
US8008453B2 (en)	2005-08-12	2011-08-30	Amgen Inc.	Modified Fc molecules
TW200813091A (en) *	2006-04-10	2008-03-16	Amgen Fremont Inc	Targeted binding agents directed to uPAR and uses thereof
JO3324B1 (en)	2006-04-21	2019-03-13	Amgen Inc	Lyophilized Therapeutic Peptibody Formulations
BR112013016107A2 (en) *	2010-12-22	2017-04-04	Ifom Fond Inst Firc Di Oncologia Molecolare	dimeric molecule, cancer treatment method, pharmaceutical composition and kit for the diagnosis of an upar-mediated pathology or tumor
CN103930128A (en)	2011-08-05	2014-07-16	意大利癌症研究基金会分子肿瘤学研究所(Ifom)	Constitutively active uPAR variants and their use in the generation and isolation of inhibitory antibodies
WO2015004148A1 (en)	2013-07-08	2015-01-15	Ifom Fondazione Istituto Firc Di Oncologia Molecolare	Biomarker of plasminogen activation system and/or of upar/vn interaction and uses thereof
WO2019165105A1 (en) *	2018-02-26	2019-08-29	The Board Of Trustees Of The Leland Stanford Junior University	Ligands of the urokinase receptor and their use in treating, detecting, and imaging cancer

1997
- 1997-03-28 WO PCT/US1997/005199 patent/WO1997035969A2/en not_active Ceased
- 1997-03-28 AU AU25978/97A patent/AU2597897A/en not_active Abandoned
- 1997-03-28 JP JP53466697A patent/JP4088344B2/en not_active Expired - Fee Related
- 1997-03-28 EP EP97917723A patent/EP0906419A2/en not_active Withdrawn
2007
- 2007-11-13 JP JP2007294871A patent/JP2008109934A/en not_active Withdrawn

Also Published As

Publication number	Publication date
WO1997035969A3 (en)	1997-11-06
EP0906419A2 (en)	1999-04-07
JP2008109934A (en)	2008-05-15
WO1997035969A2 (en)	1997-10-02
JP4088344B2 (en)	2008-05-21
JP2000509968A (en)	2000-08-08

Publication	Publication Date	Title
AU6868398A (en)	1998-10-20	Mu-opiate receptor peptides
AU2597897A (en)	1997-10-17	Peptide ligands of the urokinase receptor
AU2972097A (en)	1998-01-05	Peptide derivatives
AU6721696A (en)	1998-03-06	Cd44-like protein
AU1803597A (en)	1997-09-10	Peptide derivatives
AU2091799A (en)	1999-07-19	Uses of alpha-conotoxin peptides
AU4427296A (en)	1996-08-07	Novel peptide
AU4394396A (en)	1996-08-07	Modified peptides
AU2131195A (en)	1995-10-23	Prophenins - antibiotic peptides
AU4930399A (en)	2000-02-21	Novel Polypeptide
HUP9702220A3 (en)	1998-06-29	Urokinase receptor ligands
AU5061698A (en)	1998-06-22	Peptide derivatives
AU1999999A (en)	1999-07-19	Contryphan peptides
EP1028947B8 (en)	2004-01-28	H3 receptor ligands of the phenyl-alkyl-imidazoles type
AU6421298A (en)	1998-10-20	Novel synthetic polypeptide
AUPM489194A0 (en)	1994-04-28	Peptides
AU2886697A (en)	1997-11-19	Ball-and-socket joint
AU6275098A (en)	1998-09-08	Novel h-rev 107-like protein
AU5161296A (en)	1996-11-07	Anti-haemorrhagic peptides
AU2786297A (en)	1998-01-21	Virginiamycin mixture
AU1184800A (en)	2000-06-13	Novel polypeptide
AUPO507197A0 (en)	1997-03-06	Peptide polymers
AU9318798A (en)	1999-04-12	Ras-like protein
AU7269298A (en)	1998-11-24	New ras-like protein
AU2821695A (en)	1996-12-30	Endothelial-monocyte activating polypeptide iii